TRUVESIC - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Serial Number
97939159
Word Mark
TRUVESIC
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2023-05-19
Filing Date
2023-05-16
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Statements
Goods and Services
Pharmaceutical products, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2023-05-19
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
PERRY J. VISCOUNTY
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2023-05-19 | NEW APPLICATION ENTERED |